Free Access
Issue
Med Sci (Paris)
Volume 21, Number 6-7, Juin–Juillet 2005
Page(s) 663 - 668
Section Recherche et partenariat
DOI https://doi.org/10.1051/medsci/2005216-7663
Published online 15 June 2005
  1. Organisation Mondiale de la Santé. Guidelines for preclinical evaluation and clinical trials in osteoporosis. Geneva : WHO, 1998. [Google Scholar]
  2. Baudoin C, Fardellone P, Bean K, et al. Clinical outcomes and mortality after hip fracture : a 2-year follow-up study. Bone 1996; 18 (suppl 3) : S149–57. [Google Scholar]
  3. McCreadie BR, Goldstein SA. Biomechanics of fracture : Is bone mineral density sufficient to assess risk ? J Bone Miner Res 2000; 15 : 2305–8. [Google Scholar]
  4. Nguyen TV, Eisman JA. Genetics of fracture : challenges and opportunities. J Bone Miner Res 2000; 15 : 1253–6. [Google Scholar]
  5. Ralston SH. The genetics of osteoporosis. Bone 1999; 25 : 85–6. [Google Scholar]
  6. Harvey N, Cooper C. Determinants of fracture risk in osteoporosis. Curr Rheumatol Rep 2003; 5 : 75–81. [Google Scholar]
  7. Jordan KM, Cooper C. Epidemiology of osteoporosis. Best Pract Res Clin Rheumatol 2002; 16 : 795–806. [Google Scholar]
  8. Baron R, Tsouderos Y. In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol 2002; 450 : 11–7. [Google Scholar]
  9. Takahashi N, Sasaki T, Tsouderos Y, Suda T. S12911-2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res 2003; 18 : 1082–7. [Google Scholar]
  10. Canalis E, Hott M, Deloffre P, et al. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 1996; 18 : 517–23. [Google Scholar]
  11. Chattopadhyay N, Yano S, Tfelt-Hansen J, et al. Strontium ranelate promotes chemotaxis, stimulates proliferation and induces genes involved in the differentiation of rat primary osteoblasts. Bone 2005; 36 : S400. [Google Scholar]
  12. Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004; 350 : 459–68. [Google Scholar]
  13. Reginster JY, Seeman E, De Vernejoul MC, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis : treatment of peripheral osteoporosis (TROPOS) study. J Clin Endocrinol Metab 2005; 90 : 2916–822. [Google Scholar]
  14. Suda T, Takahashi N, Udagawa N, et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrinol Rev 1999; 20 : 345–57. [Google Scholar]
  15. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289 : 1504–8. [Google Scholar]
  16. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin : a novel secreted protein involved in the regulation of bone density. Cell 1997; 89 : 309–19. [Google Scholar]
  17. Vaananen HK, Horton M. The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure. J Cell Sci 1995; 108 : 2729–32. [Google Scholar]
  18. Manolagas SC. Birth and death of bone cells : basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrinol Rev 2000; 21 : 115–37. [Google Scholar]
  19. Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 1988; 175 : 266–76. [Google Scholar]
  20. Lorget F, Kamel S, Mentaverri R, et al. High extracellular calcium concentrations directly stimulate osteoclast apoptosis. Biochem Biophys Res Commun 2000; 268 : 899–903. [Google Scholar]
  21. Zaïdi M, Blair HC, Moonga BS, et al. Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics. J Bone Miner Res 2003; 18 :599–609. [Google Scholar]
  22. Murphy MG, Cerchio K, Stoch SA, et al. Effect of L-000845704, an alphaVbeta3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. J Clin Endocrinol Metab 2005; 90 : 2022–8. [Google Scholar]
  23. Lorget F, Mentaverri R, Meddah B, et al. Evaluation of in vitro bone resorption : high-performance liquid chromatography measurement of the pyridinolines released in osteoclast cultures. Anal Biochem 2000; 284 : 375–81. [Google Scholar]
  24. Kameda T, Mano H, Yuasa T, et al. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 1997; 186 : 489–95. [Google Scholar]
  25. Wattel A, Kamel S, Mentaverri R, et al. Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem Pharmacol 2003; 65 : 35–42. [Google Scholar]
  26. Mentaverri R, Kamel S, Wattel A, et al. Regulation of bone resorption and osteoclast survival by nitric oxide : possible involvement of NMDA-receptor. J Cell Biochem 2003; 88 : 1145–56. [Google Scholar]
  27. Wattel A, Kamel S, Prouillet C, et al. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NFkappa B and AP-1. J Cell Biochem 2004; 92 : 285–95. [Google Scholar]
  28. Iotsova V, Caamano J, Loy J, et al. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 1997; 3 : 1285–9. [Google Scholar]
  29. Grigoriadis AE, Wang ZQ, Cecchini MG, et al. c-Fos : a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994; 266 : 443–8. [Google Scholar]
  30. Malgaroli A, Meldolesi J, Zallone AZ, et al. Control of cytosolic free calcium in rat and chicken osteoclasts. The role of extracellular calcium and calcitonin. J Biol Chem 1989; 264 :14342–7. [Google Scholar]
  31. Datta HK, MacIntyre I, Zaidi M. The effect of extracellular calcium elevation on morphology and function of isolated rat osteoclasts. Biosci Rep 1989; 9 : 747–51. [Google Scholar]
  32. Mentaverri R, Kamel S, Brazier M. Involvement of capacitive calcium entry and calcium store refilling in osteoclastic survival and bone resorption process. Cell Calcium 2003; 34 : 169–75. [Google Scholar]
  33. Mentaverri R, Hurtel AS, Kamel S, et al. Strontium ranelate directly stimulates osteoclast apoptosis. Osteoporos Int 2004; 15 (suppl 1) : P345MO. [Google Scholar]
  34. Mentaverri R, Hurtel AS, Wattel A, et al. Calcium-sensing receptor mediates strontium ranelate-induced osteoclasts apoptosis. Bone 2005; 36 : S403. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.